Christine Nash

Christine Nash

Director/Board Member at RALLYBIO CORPORATION

Net worth: - $ as of 31/03/2024

51 year
Health Technology
Commercial Services
Consumer Services

Profile

Christine A.
Nash
is currently a Director at Rallybio Corp.
Prior to her current position, she held various roles including Chairman at CM Group, Marketing Director at CoTherix, Inc., Principal at Eli Lilly & Co. and Genesoft Pharmaceuticals, Inc., VP-Strategic Marketing & Business Development at Hyperion Therapeutics, Inc., and Principal at Oncology Therapeutics Network Corp., Imana, Inc., and Chatiemac Consulting LLC.
Nash received her undergraduate degree and MBA from Stanford University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/03/2024 0 ( -.--% ) - $ 31/03/2024

Christine Nash active positions

CompaniesPositionStart
RALLYBIO CORPORATION Director/Board Member 04/04/2022
All active positions of Christine Nash

Former positions of Christine Nash

CompaniesPositionEnd
Chatiemac Consulting LLC Corporate Officer/Principal -
Imana, Inc. Corporate Officer/Principal -
Chairman -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Christine Nash's experience

Training of Christine Nash

Stanford University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christine Nash's experience

Connections

22

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ELI LILLY AND COMPANY

Health Technology

RALLYBIO CORPORATION

Health Technology

Private companies7
Genesoft Pharmaceuticals, Inc.

Commercial Services

Health Technology

Health Technology

Distribution Services

Imana, Inc.

Technology Services

Chatiemac Consulting LLC

See company connections
  1. Stock Market
  2. Insiders
  3. Christine Nash